Clinical Trial Update: Austrian Multivessel Taxus-Stent Registry [Phase 4]

View source ↗

Summary

This clinical trial update notes the completion of the Austrian Multivessel Taxus-Stent Registry (Phase 4) in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Taxus Stent (paclitaxel-eluting stent)

Snippet

Sponsor: Medical University of Vienna | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED